Technology, Science, & Me!
SEE OTHER BRANDS

Get your daily news on science and technology

Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on July 30, 2025

Omega Flex, Inc. Announces Second Quarter 2025 Earnings

Omega Flex, Inc. Announces Second Quarter 2025 Earnings

EXTON, Pa., July 30, 2025 (GLOBE NEWSWIRE) --       OMEGA FLEX, INC. (OFLX)   Six Months Ended June 30,   Three Months Ended June 30,                       2025   2024   2025   2024                     Net Sales $ 48,855,000     $ 49,836,000     $ 25,525, …

COMSTOCK RESOURCES, INC. REPORTS SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS

COMSTOCK RESOURCES, INC. REPORTS SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS

FRISCO, TX, July 30, 2025 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE; NYSE Texas: CRK) today reported financial and operating results for the quarter ended June 30, 2025. Highlights of 2025's Second Quarter Higher …

Brag House Announces Closing of $15 Million Private Placement

Brag House Announces Closing of $15 Million Private Placement

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”) the Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, announces today that it has closed …

Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for …

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …

Tenable Announces Second Quarter 2025 Financial Results

Tenable Announces Second Quarter 2025 Financial Results

Revenue of $247.3 million, up 12% year-over-year. Calculated current billings of $238.6 million, up 8% year-over-year. GAAP operating margin of (3)%; Non-GAAP operating margin of 19%. Net cash provided by operating activities of $42.5 million; Unlevered …

Gulf Island Announces Second Quarter 2025 Results Conference Call Date

Gulf Island Announces Second Quarter 2025 Results Conference Call Date

THE WOODLANDS, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI), a leading steel fabricator and service provider to the industrial, energy and government sectors, today announced that it …

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …

SPS Commerce Reports Second Quarter 2025 Financial Results

SPS Commerce Reports Second Quarter 2025 Financial Results

Company delivers 98th consecutive quarter of topline growth Second quarter 2025 revenue grew 22% and recurring revenue grew 24% from the second quarter of 2024 MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in …

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

TTM Technologies, Inc. Reports Second Quarter 2025 Results

TTM Technologies, Inc. Reports Second Quarter 2025 Results

SANTA ANA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies …

TTM Technologies, Inc. Announces Retirement Plans of its CEO and Proceeds with CEO Successor Search

TTM Technologies, Inc. Announces Retirement Plans of its CEO and Proceeds with CEO Successor Search

SANTA ANA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, …

AMSC Reports First Quarter Fiscal Year 2025 Financial Results and Business Outlook

AMSC Reports First Quarter Fiscal Year 2025 Financial Results and Business Outlook

First Quarter Financial Highlights: Increased Revenue by 80% Year Over Year to Above $70 Million Reported Net Income of Over $6 Million and Non-GAAP Net Income Exceeding $11 million Achieved Gross Margin Greater than 30% Company to host conference call …

Climb Global Solutions Reports Second Quarter 2025 Results

Climb Global Solutions Reports Second Quarter 2025 Results

EATONTOWN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is …

Applied Digital Reports Fiscal Fourth Quarter and Full Year 2025 Results

Applied Digital Reports Fiscal Fourth Quarter and Full Year 2025 Results

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for high-performance computing (“HPC”) …

IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients

IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients

iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens clinical utility for dd-cfDNA with …

Codexis to Report Second Quarter 2025 Financial Results on August 13

Codexis to Report Second Quarter 2025 Financial Results on August 13

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results …

Pulmonx Reports Second Quarter 2025 Financial Results

Pulmonx Reports Second Quarter 2025 Financial Results

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2025 …

Hawkins, Inc. Increases its Quarterly Cash  Dividend by 6% to $0.19 Per Share

Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record …

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the company will host a conference call and webcast on Wednesday, August 6, 2025 at 4:30 p.m. ET to discuss updated clinical data …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions